SunAct Cancer Institute and CytoMed begin phase 2 trials for Gamma Delta T-cell therapy
Collaborative trials aim to advance affordable cancer treatment for solid tumours in India
Recover your password.
A password will be e-mailed to you.
- Advertisement -
- Advertisement -
Recover your password.
A password will be e-mailed to you.